Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-06-08, Stock:NVS, The news for the past five days is as follows:
2018-06-01: NEWS1: How Novartis, Insurers Are Taking Wind Out Of AbbVie&apos;s Sales.NEWS2: Novartis readies anti-sexism message for migraine drug.NEWS3: Novartis, aiming to go toe-to-toe with Humira, wins EU panel nod.NEWS4: Novartis, aiming to go toe-to-toe with Humira, wins EU panel nod.NEWS5: The Swiss Stock Market Jumped After Italy And Spain Get New Leadership.NEWS6: The Swiss Stock Market Jumped After Italy And Spain Get New Leadership.NEWS7: Novartis Completes Divestment Of Stake In Consumer Healthcare JV - Quick Facts.NEWS8: Novartis Completes Divestment Of Stake In Consumer Healthcare JV - Quick Facts.NEWS9: Novartis Gets Positive CHMP Opinion For Aimovig For Prevention Of Migraine.NEWS10: Novartis Gets Positive CHMP Opinion For Aimovig For Prevention Of Migraine.NEWS11: Sandoz Gets Positive CHMP Opinion For Proposed Biosimilar Adalimumab.NEWS12: Sandoz Gets Positive CHMP Opinion For Proposed Biosimilar Adalimumab.
2018-06-04: NEWS1: Novartis Announces Positive Data on Kisqali and Tasigna.NEWS2: 3 Stocks Raising Hopes in Troubled Large-Cap Pharma Industry.NEWS3: 3 Stocks Raising Hopes in Troubled Large-Cap Pharma Industry.NEWS4: The Swiss Stock Market Clung To A Small Gain.NEWS5: The Swiss Stock Market Clung To A Small Gain.NEWS6: European Markets Rose As Political Tensions Continue To Ease.NEWS7: European Markets Rose As Political Tensions Continue To Ease.NEWS8: European Shares Extend Gains On M&A News.NEWS9: European Shares Extend Gains On M&A News.
2018-06-05: NEWS1: Watch Out Amgen, Here Comes Mylan.NEWS2: Watch Out Amgen, Here Comes Mylan.NEWS3: The Swiss Stock Market Pulled Back On Broad Weakness.NEWS4: The Swiss Stock Market Pulled Back On Broad Weakness.NEWS5: [$$] Doubts over judicial fairness will hold back Greece.NEWS6: FDA Approves First Neulasta Biosimilar, HQY Hits New High, TGTX Turns Heads.NEWS7: FDA Approves First Neulasta Biosimilar, HQY Hits New High, TGTX Turns Heads.NEWS8: Novartis Announces Positive Data on Kisqali and Tasigna.NEWS9: Novartis Announces Positive Data on Kisqali and Tasigna.
2018-06-06: NEWS1: A Look at Novartis Stock in May.NEWS2: [$$] The Novartis-Cohen Connection Explained.NEWS3: Treasury Department Hasn't Responded to Cohen Probe Request.NEWS4: Novartis Won't Be Investigated by Swiss Over Payments to Cohen.NEWS5: ASCO Ends: Winners & Losers at the Key Cancer Research Event.NEWS6: ASCO Ends: Winners & Losers at the Key Cancer Research Event.NEWS7: Swiss prosecutors will not pursue Novartis over Trump lawyer payments.NEWS8: ASCO Ends: Winners & Losers at the Key Cancer Research Event.NEWS9: The Swiss Stock Market Held Onto A Small Gain.NEWS10: The Swiss Stock Market Held Onto A Small Gain.NEWS11: [$$] Swiss prosecutors will not open proceedings against Novartis over Trump lawyer payments.
2018-06-07: NEWS1: Axovant (AXON) Gains on Licensing Deal with Oxford BioMedica.NEWS2: Axovant (AXON) Gains on Licensing Deal with Oxford BioMedica.NEWS3: Does Novan Inc’s (NASDAQ:NOVN) Earnings Growth Make It An Outperformer?.NEWS4: The Swiss Stock Market Finished With A Slight Gain After Early Profits Erode.NEWS5: The Swiss Stock Market Finished With A Slight Gain After Early Profits Erode.

Answer: Decrease